UCSF navigation bar UCSF home page UCSF home page About UCSF Search UCSF UCSF Medical Center
schools of
pharmacy &medicine
Rxforchange

FAQ

Q.
How do I gain access to the Rx for Change materials?
A.
The program materials can be downloaded from our website. All persons who receive any component of the Rx for Change program must complete the online registration process, which includes acceptance of our End-User Licensing Agreement.
Q.
How much do the materials cost?
A.
We provide all materials at no cost.
Q.
Do you conduct train-the-trainer programs? And do you have web-based continuing education programs?
A.
We provide live train-the-trainer programs upon request. Also, we have developed various web-based continuing education programs, including a 6-hr train-the-trainer program. These can be found at https://ce.pharmacy.purdue.edu/content/intro-tobacco-cessation and are available for CE credit at no cost. To schedule a training or to inquire about other training options, contact us at rxfc@pharmacy.ucsf.edu.
Q.
The Rx for Change program was initially created for pharmacy students. Can it be used with students in other health disciplines?
A.
Yes. Our materials are appropriate for all health disciplines.
Q.
Can the materials be used to train licensed health care professionals?
A.
Yes. Although Rx for Change was initially designed for training students in the health professions, the program also is used for training licensed health professionals. For the 5 A’s version, we recommend a 6- to 8-hour workshop. Tailored versions are available, and these range from 1 to 4 hours in duration.
Q.
Have the Rx for Change materials been externally reviewed?
A.
Yes, our materials have undergone two rounds of external review and continuous updates and quality improvement. Our external reviewers for the 5 A’s version are:
Neal Benowitz, MD, University of California San Francisco School of Medicine
Bruce A. Berger, PhD, RPh, Auburn University School of Pharmacy
Carlo C. DiClemente, PhD, University of Maryland Baltimore County
Stanton A. Glantz, PhD, University of California San Francisco
Alexander V. Prokhorov, MD, PhD, MD Anderson Cancer Center
Frank Vitale, MA, National Director, Pharmacy Partnership for Tobacco Cessation
Note: Our tailored versions also have undergone extensive external review (list of reviewers available upon request).
Q.
Are there instructions describing how to implement the Rx for Change program?
A.
Yes. We have created a comprehensive Faculty Coordinator's Guide — this document provides a complete description of all facets of program implementation.
Q.
Has the program been used internationally?
A.
Yes, Rx for Change has been used in many countries, for teaching students and clinicians as well as for training clinician participants in research studies. Portions of the program have been translated into Spanish and Chinese. For more information about international initiatives, please contact us at rxfc@pharmacy.ucsf.edu.
Q.
Who can use the Rx for Change materials?
A.
We openly share our materials with all educators and encourage their use within the bounds specified in the End-User Licensing Agreement.
Q.
Once I receive access to the Rx for Change materials, can I share the electronic files, materials, and/or my Web access codes with others?
A.
If others wish to use the Rx for Change materials, please advise them to initiate their own online account. The End-User Licensing Agreement permits you to reproduce, distribute, perform publicly and display publicly the Rx for Change materials for non-commercial, not-for-profit educational use only. Specific information about the use of the Rx for Change materials is detailed in the End-User Licensing Agreement. For other proposed uses, please contact Karen Hudmon at khudmon@purdue.edu.
Q.
Who owns the Rx for Change materials?
A.
The program materials were developed by faculty from the University of California San Francisco, and the copyright for all versions of the program is represented by The Regents of the University of California.
Q.
Who are the primary developers of the Rx for Change Program content?
A.
The primary Rx for Change developers are:
Robin L. Corelli, PharmD, UCSF School of Pharmacy
William Grossman, MD, UCSF School of Medicine (cardiology version)
Karen S. Hudmon, DrPH, MS, RPh, Purdue University College of Pharmacy
Lisa A. Kroon, PharmD, UCSF School of Pharmacy
Judith J. Prochaska, PhD, MPH, Stanford University (psychiatry, cardiology versions)
David O. Warner, MD, Mayo Clinic (surgical version)
UCSF Smoking Cessation Leadership Center (Ask-Advise-Refer, mental health peer counselor versions)
Q.
What funding organizations have supported the Rx for Change program?
A.
The Rx for Change program was developed almost entirely through volunteer efforts of faculty across California. Limited funds were available from the California Department of Health Services, Tobacco Control Section and the University of California San Francisco Instructional Grants Program. The University of California Tobacco-Related Disease Research Program provided funding for the early phases of our program evaluation and also kindly provided bridging support to facilitate finalization of the program until additional funding was received from the National Cancer Institute. Psychiatry Rx for Change also has been funded by the California TRDRP. The Smoking Cessation Leadership Center at the University of California San Francisco, through funding from the Robert Wood Johnson Foundation and the American Legacy Foundation, has assisted with development of several of the tailored versions as well as ongoing dissemination of the Rx for Change program. Cardiology Rx for Change was funded by the Flight Attendant Medical Research Institute.
Q.
What's the story behind the petition against tobacco sales in pharmacies, on the main page of your website?
A.
For several years, our research team has been engaged in an effort to eliminate tobacco sales in pharmacies. We hope that a collective list (banding together the voices of pharmacists, pharmacy students, other health professionals, consumers, etc.) will raise awareness and ultimately remove the single most important cause of preventable death in our country from our pharmacy shelves. Our research has facilitated successful legislative efforts in San Francisco and subsequently in other locations across the U.S.